Pre-IVF treatment with a GnRH antagonist in women with endometriosis - A prospective double-blind placebo-controlled trial JHM IRB
Primary Objective
To investigate the use of Orilissa to treat endometriosis prior to in-vitro fertilization procedures.
Description
This study is looking for women with endometriosis that are about to start in-vitro fertilization procedures to see how Orilissa, a drug to help with symptoms of endometriosis, affects fertility treatment. Participants can expect up to 5 study visits spanning over approximately 6 months, entailing a 60-day drug period and the fertility treatment itself. You must be willing to take a medication and undergo blood draws, fertility treatments, and assessments.
Details
Locations
Outpatient CTRC
SGF Colorado - Colorado Springs
SGF Colorado - Denver
Principal Investigator
Nanette Santoro
Study ID
Protocol Number: 19-3115
More information available at ClinicalTrials.gov: NCT04173169
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers